CINECA IRIS Institutional Research Information System

PASQUALI, LIVIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.918
EU - Europa 3.528
AS - Asia 1.253
AF - Africa 151
OC - Oceania 22
SA - Sud America 12
Continente sconosciuto - Info sul continente non disponibili 1
Totale 11.885
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.692
IT - Italia 1.629
CN - Cina 602
SE - Svezia 485
DE - Germania 359
BG - Bulgaria 322
CA - Canada 225
TR - Turchia 172
GB - Regno Unito 165
SG - Singapore 164
UA - Ucraina 151
VN - Vietnam 139
FI - Finlandia 122
AT - Austria 93
CI - Costa d'Avorio 86
IN - India 82
CH - Svizzera 63
HK - Hong Kong 53
SN - Senegal 39
FR - Francia 36
RU - Federazione Russa 32
NG - Nigeria 20
PL - Polonia 19
BE - Belgio 15
NZ - Nuova Zelanda 13
AU - Australia 9
ES - Italia 9
IR - Iran 9
BR - Brasile 7
IE - Irlanda 7
JP - Giappone 7
KR - Corea 6
NL - Olanda 6
ID - Indonesia 5
DK - Danimarca 4
AR - Argentina 3
EG - Egitto 3
MA - Marocco 3
TW - Taiwan 3
CZ - Repubblica Ceca 2
GR - Grecia 2
HR - Croazia 2
HU - Ungheria 2
IQ - Iraq 2
PK - Pakistan 2
PT - Portogallo 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
CR - Costa Rica 1
EC - Ecuador 1
EU - Europa 1
KW - Kuwait 1
LU - Lussemburgo 1
OM - Oman 1
PE - Perù 1
PH - Filippine 1
TH - Thailandia 1
UZ - Uzbekistan 1
Totale 11.885
Salva come PNG Salva come JPEG
Città #
Woodbridge 1.096
Ann Arbor 869
Houston 622
Chandler 597
Fairfield 524
Serra 460
Sofia 319
Milan 310
Ashburn 302
Wilmington 257
Seattle 222
Beijing 219
New York 211
Ottawa 204
Jacksonville 202
Cambridge 195
Izmir 167
Princeton 144
Florence 129
Lawrence 129
Medford 119
Nanjing 112
Vienna 90
Abidjan 86
Des Moines 71
Dong Ket 66
Nanchang 58
Rome 57
Pisa 55
Bern 54
Livorno 54
Hong Kong 49
Dearborn 47
London 42
Bremen 41
Jüchen 40
Dakar 39
Fondi 39
Redwood City 38
Falls Church 30
San Diego 30
Boulder 27
Pune 27
Hebei 24
Los Angeles 23
Shenyang 23
Kunming 22
Lancaster 21
Frankfurt am Main 20
Lagos 20
Changsha 19
Norwalk 18
Warsaw 18
Boardman 17
Dallas 15
Ogden 15
Tianjin 15
Detroit 14
Brussels 13
Hangzhou 13
Hefei 13
Jiaxing 13
Nürnberg 13
Düsseldorf 12
Trieste 12
Orange 10
Washington 10
Auburn Hills 8
Christchurch 8
Grafing 8
Verona 8
Chengdu 7
Costa Mesa 7
Toronto 7
Austin 6
Chandigarh 6
Guangzhou 6
Lanzhou 6
Marseille 6
Piombino 6
Singapore 6
Auckland 5
Bari 5
Dublin 5
Greenlawn 5
Phoenix 5
Rapino 5
Zurich 5
Bagnolo Piemonte 4
Genoa 4
Jakarta 4
Jinan 4
Leawood 4
Madrid 4
Montréal 4
Monza 4
Ningbo 4
San Francisco 4
Shanghai 4
Tappahannock 4
Totale 9.020
Salva come PNG Salva come JPEG
Nome #
MPTP Neurotoxicity: Actions, Mechanisms, and Animal Modelling of Parkinson’s Disease 206
The role of mitochondria in stem cell biology 167
CINRG pilot trial of coenzyme Q10 in steroid-treated Duchenne muscular dystrophy. 155
Clinical Trials for Neuroprotection in ALS 147
The effect of air pollution on COVID-19 severity in a sample of patients with multiple sclerosis 143
Astrocyte-neuron interactions in neurological disorders 141
Lack of association between the APEX1 Asp148Glu polymorphism and sporadic amyotrophic lateral sclerosis 138
Cardiac magnetic resonance imaging and management of dilated cardiomyopathy in a Duchenne muscular dystrophy manifesting carrier 138
Impaired oxidative metabolism in exercising muscle from ALS patients. 136
Facioscapulohumeral muscular dystrophy type 1A in northwestern Tuscany: a molecular genetics-based epidemiological and genotype-phenotype study 135
Relation between plasmatic and cerebrospinal fluid oxidative stress biomarkers and intrathecal ig synthesis in multiple sclerosis patients 134
A clinical and laboratory study evaluating the profile of cytokine levels in relapsing remitting and secondary progressive multiple sclerosis 133
The Italian multiple sclerosis register 133
Oxidative stress modulation in neurodegenerative diseases 131
The role of mitochondria in stem cell biology 131
The Role of Mitochondria in StemCell Biology 130
CINRG randomized controlled trial of creatine and glutamine in Duchenne muscular dystrophy 129
Long-term follow-up of 106 multiple sclerosis patients undergoing IFN-ß 1a or 1b therapy: predictive factors of thyroid disease development and duration 128
Lack of association between the APEX1 Asp148Glu polymorphism and sporadic Amyotrophic Lateral Sclerosis 128
Gly482Ser PGC-1α gene polymorphism and exercise-related oxidative stress in amyotrophic lateral sclerosis patients 128
Activation of brain metabolism and fos during limbic seizures: The role of Locus Coeruleus 126
Amyotrophic lateral sclerosis with long lasting disease course and SOD1 and TARDBP mutations: Report of two cases and overview of the literature. 126
Alteration of lactate production during incremental excercise in myotonic dystrophy is not dependent by catecholamine increase 124
Intracellular pathways underlying the effects of lithium 124
Abnormal levels of human mitochondrial transcription factor A in skeletal muscle in mitochondrial encephalomyopathies. 124
MPTP-induced Parkinsonism is associated with damage to Leydig cells and testosterone loss 123
Strategies for clinical approach to neurodegeneration in Amyotrophic lateral sclerosis. 119
Collaborative translational research leading to multicenter clinical trials in Duchenne muscular dystrophy: the Cooperative International Neuromuscular Research Group (CINRG) 118
Neurophysiological evaluation of vigilance in epileptic patients on monotherapy with lamotrigine 116
Assessment of endogenous DNA oxidative stress in mitochondrial encephalomyopathies. 113
Sustained wakefulness combined with blood alcohol legal concentrations: effects on car driving performance. 113
Does autophagy worsen or improve the survival of dopaminergic neurons? 113
H-MTTFA muscle levels in mitochondrial myopathies. 113
Alpha-synuclein and autophagy as common steps in neurodegeneration 112
Lack of α1b-adrenergic receptor protects against epileptic seizures 112
Clinical and demographic features of multiple sclerosis in an Italian register: a cross-sectional ecologic study 111
A case of comorbidity between multiple sclerosis and multiple system atrophy 108
Metabolic muscle adaptation to aerobic training in patients affected by mitochondrial myopathies. 108
Role of autophagy during methamphetamine neurotoxicity 108
High number of striatal dopaminergic neurons during early postnatal development: correlation analysis with dopaminergic fibers 105
Gastric emptying in myotonic dystrophic patients. 103
Spinal cord and parkinsonism: Neuromorphological evidences in humans and experimental studies. 103
Autophagy, lithium, and amyotrophic lateral sclerosis 102
Motor neuron pathology and behavioral alterations at late stages in a SMA mouse model. 101
Predictive factors of thyroid disease during sustained INF-ß therapy in 106 multiple sclerosis patients 101
Do Thyroid autoimmunity and dysfunction predict clinical outcome of multiple sclerosis patients trated with IFN-β? 100
Molecular diagnostics and mitochondrial dysfunction: a future perspective 100
Genetic or pharmacological blockade of noradrenaline synthesis enhances the neurochemical, behavioral, and neurotoxic effects of methamphetamine 99
Metabolic and muscle adaptation to aerobic training in CPEO patients. 98
Lactate production and catecholamine profile during aerobic exercise in normotensive OSAS patients 98
Limb girdle muscular dystrophy type 2a associated with epilepsy: a case report. 98
MPTP- but not methamphetamine-induced parkinsonism extends to catecholamine neurons in the gut 95
Cell To Cell Spreading Of Misfolded Proteins As A Therapeutic Target In Motor Neuron Disease. 95
Plasma redox and inflammatory patterns during major depressive episodes: A cross-sectional investigation in elderly patients with mood disorders 95
Plasmatic oxidative stress biomarkers in multiple sclerosis: Relation with clinical and demographic characteristics. 95
Methamphetamine Fails to Alter the Noradrenergic Integrity of the Heart A Comparison with the Parkinsonism-Inducing Neurotoxin MPTP 94
Review of the clinical evidence for interferon beta 1a (Rebif) in the treatment of multiple sclerosis 93
Effects of Alzheimer's disease and mild cognitive impairment on driving ability: a controlled clinical study by simulated driving test 93
Facio-scapulo-humeral dystrophy in north-west Tuscany: a molecular genetics-based epidemiological and genotype-phenotype study 93
Facio-scapulo-humeral muscular dystrophy in North-West Tuscany: A clinically and molecularly based epidemiological study 92
Occurrence of IgG oligoclonal bands in upper motor neuron disease: just by chance? 92
Pharmacogenetics of myotonic hNav1.4 sodium channel variants situated near the fast inactivation gate. 92
Caso clinico: cardiopatia in una portatrice di distrofia muscolare di Duchenne 91
Oxidative stress in myotonic dystrophy type 1 90
Frederich’s ataxia: a case report. 90
Parkinson’s disease and the gut: a well known clinical association in need of an effective cure and explanation 90
Profiling of Canonical and Non-Traditional Cytokine Levels in Interferon-β-Treated Relapsing-Remitting-Multiple Sclerosis Patients 90
Kennedy’s disease: a case report. 88
Subacute Alzheimer’s disease with prominent white matter involvement. Report of a pathologically-confirmed case 87
Miopatie tossiche e da farmaci 86
Magnetization Transfer Imaging Of Cortical Motor System In Als Patients At Early Stage of Disease 86
Facio-scapulo-humeral dystrophy in north-west Tuscany: a molecular genetics-based epidemiological and genotype-phenotype study 84
Defining disease pathogenesis by comparative cross-species profiling in human and mouse knock-outs: the downstream consequences of dystrophin deficiency. 84
Advanced oxidation protein products in serum of patients with myotonic disease type I: association with serum gamma-glutamyltransferase and disease severity 84
Epidemiology of facio-scapulo-humeral dystrophy in north-west Tuscany: a molecular genetics-based revisitation. 83
Complicanze gastrointestinali in pazienti neurologici trattati con glucocorticoidi: terapia con gli inibitori di pompa protonica 83
Cardiomiopatia dilatativa familiare associata a miopatia 83
Pathways of methamphetamine toxicity 83
DMTs and Covid-19 severity in MS: a pooled analysis from Italy and France 83
Malattie neurologiche in gravidanza 82
Plasmatic oxidative stress biomarkers in multiple sclerosis patients with different clinical course 82
H-MTTFA muscle levels in mitochondrial myopathies 81
Very late onset multiple sclerosis likely associated with restless legs syndrome. A case report. 81
Altered lactate kinetics from exercising muscle in Hereditary Spastic Paraplegia. 80
The importance of nasal resistance in obstructive sleep apnea syndrome: a study with positional rhinomanometry. 80
The role of autophagy: what can be learned from the genetic forms of amyotrophic lateral sclerosis 78
Sudden death in epilepsy: Two case reports 76
Creatine and glutamine therapeutic trial in Duchenne muscular dystrophy (DMD) by the Cooperative International Neuromuscular Research Group (CINRG) 76
Chronic inflammatory demyelinating polyradiculoneuropathy in children 75
Defining disease pathogenesis by comparative cross-species profiling in human and mouse knock-outs: the downstream consequences of dystrophin deficiency. 75
Effetti psichici e comportamentali dei farmaci antiepilettici nell’adulto 75
PLASMATIC AND CEREBROSPINAL FLUID OXIDATIVE STRESS BIOMARKERS IN ACUTE AND CHRONIC POLYRADICULONEUROPATHIES 75
Multiple Sclerosis and Neurofibromatosis type1: case report 75
Defining disease pathogenesis by comparative cross-species profiling in human and mouse knock-outs: the downstream consequences of dystrophin deficiency 74
Long-term follow-up of 106 multiple sclerosis patients undergoing interferon-beta 1a or 1b therapy: predictive factors of thyroid disease development and duration 74
I farmaci inibitori delle colinesterasi nel trattamento dei disturbi psichici e comportamentali nella malattia di Azheimer: focus su galantamina 72
Paralisi facciale di Bell 71
Diagnosi e terapia della malattia di Parkinson 69
Reliability, practice effects, and change indices for Rao's Brief Repeatable Battery 69
RELEVANCE OF COGNITIVE DETERIORATION IN EARLY RELAPSING-REMITTING MS: A 3-YEAR FOLLOW-UP STUDY 69
Totale 10.313
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.511
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.511
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019369 0 0 0 0 0 0 0 0 0 0 214 155
2019/20202.142 261 205 412 102 160 176 207 112 158 101 229 19
2020/2021877 81 25 76 73 86 28 84 86 66 66 57 149
2021/20221.473 23 108 27 71 287 204 51 109 78 46 92 377
2022/20232.040 199 249 139 195 231 273 33 146 340 18 193 24
2023/20241.386 184 156 252 112 207 281 61 29 31 54 19 0
Totale 12.094